38559-90-9 Usage
Description
(4-Phenoxyphenoxy)acetic acid, also known as 4-Phenoxy-Phenoxyacetic acid, is a synthetic compound with the chemical formula C14H12O4. It is characterized by its ability to act as a selective herbicide, targeting post-emergent broadleaf weeds in agricultural settings.
Used in Agricultural Industry:
(4-Phenoxyphenoxy)acetic acid is used as a selective herbicide for controlling post-emergent broadleaf weeds in crops such as soybeans, peanuts, and sorghum. It functions by disrupting the growth and development of the weeds, ultimately leading to their death. This selective action allows for effective weed control without causing significant harm to the desired crops.
(4-Phenoxyphenoxy)acetic acid is considered to have low toxicity to mammals, making it a relatively safer option for use in agricultural settings. However, it is crucial to handle and use this compound with caution to minimize potential environmental and health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 38559-90-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,5,5 and 9 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 38559-90:
(7*3)+(6*8)+(5*5)+(4*5)+(3*9)+(2*9)+(1*0)=159
159 % 10 = 9
So 38559-90-9 is a valid CAS Registry Number.
InChI:InChI=1/C14H12O4/c15-14(16)10-17-11-6-8-13(9-7-11)18-12-4-2-1-3-5-12/h1-9H,10H2,(H,15,16)
38559-90-9Relevant articles and documents
In silico and pharmacological screenings identify novel serine racemase inhibitors
Mori, Hisashi,Wada, Ryogo,Li, Jie,Ishimoto, Tetsuya,Mizuguchi, Mineyuki,Obita, Takayuki,Gouda, Hiroaki,Hirono, Shuichi,Toyooka, Naoki
, p. 3732 - 3735 (2014/09/03)
d-Serine is a coagonist of the N-methyl-d-aspartate (NMDA)-type glutamate receptor and its biosynthesis is catalyzed by serine racemase (SR). The overactivation of the NMDA receptor has been implicated in the development of neurodegenerative diseases, strokes, and epileptic seizures, thus, the inhibitors of SR have potential against these pathological states. Here, we have developed novel inhibitors of SR by in silico screening and in vitro enzyme assay. The newly developed inhibitors have lower IC50 value comparing with that of malonate, one of the standard SR inhibitor. The structural features of novel inhibitors suggest the importance of central amide structure having a phenoxy substituent in their structure for the SR inhibitory activity. The present findings suggest the importance and rational development of new drugs for diseases of NMDAR overactivation.
RESEARCH ON DIPHENYL ETHER DERIVATIVES. NEW 2-METHYLIMIDAZOLINES.
NARDI
, p. 41 - 47 (2007/10/06)
-
